Product Information
- N-[2-[5-(aminoiminomethyl)-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]-3,5-difluoro-4-pyridinyl]-N-methyl glycineCI 1031Fidexaban
- Zk-807834
- Bx-807834
- ZK-807191(diHCl)
- Pd-200022
- Ci-1031
- N-[(2-{[3-(diaminomethylidene)-6-oxocyclohexa-1,4-dien-1-yl]oxy}-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl)methyl]glycine
Fidexaban is a low molecular weight heparin with antithrombotic properties. It has been shown to be effective in preventing thrombosis, including pulmonary embolism and deep vein thrombosis, and for the treatment of coronary artery disease. Fidexaban is a competitive inhibitor of heparin that binds to the active site of serine proteases. The binding prevents these enzymes from cleaving the substrate and leads to an increase in soluble guanylate cyclase activity, which inhibits platelet aggregation and reduces blood clotting. Fidexaban also binds to proteins on the surface of red blood cells and inhibits platelet aggregation. This drug is classified as a low molecular weight heparin because it has a molecular weight of less than 5000 Da.
Chemical properties
Technical inquiry about: 3D-FF23284 Fidexaban
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.